Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDRH ombudsman’s report

This article was originally published in The Gray Sheet

Executive Summary

Number of contacts received by CDRH Ombudsman Les Weinstein in 2004 grew to 125, up from 120 in 2003, according to the 1ombudsman's annual report. Industry accounted for 90% of 2004 contacts, compared with 78% in 2003 (2"The Gray Sheet" April 5, 2004, p. 8). The Office of Device Evaluation remains the office most often involved with disputes/complaints (66%). Premarket notifications are still the most cited subject for disputes/complaints (28%), while inspections (4%) and HDEs (2%) were added to the list for the first time in 2004. Miscommunication or lack of communication continues to be the top reason for complaints/disputes (25%), followed by "least burdensome" issues (16%). By the end of 2004, about 35% of complaints/disputes were pending, 31% resolved, 21% withdrawn or not followed-up and 13% referred outside CDRH. In 2003, 26% were resolved and 22% were pending...

Related Content

UsernamePublicRestriction

Register

MT021553

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel